I’m in no rush... honestly, it’s a gift to have them trading so low. I used to hate how slow they moved and their lack of expansion but now they have the advantage- everyone else over estimated and over spent. In this case; slow was smooth and smooth was fast. They are building a brand synonymous w quality, have some pretty interesting partnerships and a lot of catalysts in the near term. Germany sales, Australian clinical trail data, more provincial agreements, wax-shatter-rosin- edibles data etc etc. They are carefree and approaching profitability in a highly stressed and beaten down market. Revenues shld rise exponentially w new products hitting shelves and law enforcement beginning to clean up the blackmarket.
I see blue skys ahead. GLTA
News 
Market Data 
Discover 
